Alternatives to PhaseV

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Drug discovery and development company using a novel technological approach.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

AI-driven platform for protein-level disease mapping and drug discovery.

Omnix Medical is developing a novel platform for advanced wound care management.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Compressing biology to develop the next generation of therapies.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

EU-based company providing personalized medicine solutions for medical practitioners.

Developing novel therapeutic approaches for ocular diseases.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

AI-powered digital platform for life sciences, accelerating clinical research and drug development.

AI-enabled technology for cell biology research and biopharma development.

AI-driven digital twin of embryo development for cell-based therapies.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

AI-powered platform accelerating biological research and drug discovery.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Biotechnology company developing novel therapies for multiple myeloma.

AI-powered blood test for early cancer detection and subtyping.

Own Chemex.ai today. Secure checkout and guided transfer support. No hidden fees.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Develops a platform for individual drug customization using aptamers for cancer treatment.

AI-powered insights platform for life sciences and biotech workflows.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Develops autologous engineered tissue from omentum biopsies for medical conditions.